Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer
Open Access
- 24 January 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Abstract
The study aims to evaluate the survival impact of primary tumor resection (PTR) on thoracic esophageal cancer with distant metastasis(TECDM). Data of patients with TECDM was collected from the Surveillance, Epidemiology, and End Results database(SEER) from 2010 to 2020. A 1:1 propensity-score matching(PSM) analysis was employed to minimize heterogeneity between the groups. Total 7733 patients with TECDM were included in the analysis, of which 121 underwent primary tumor resection and 7612 did not. Patients who underwent primary tumor resection exhibited better median overall survival(OS) and median cancer-specific survival(CSS) compared to those who did not, in both the overall and PSM cohort. In the PSM cohort, the median OS was 11 months (95% CI, 9 to 13 months) for TECDM patients who underwent PTR, compared to 7 months (95% CI, 5 to 9 months) for those who did not. Furthermore, Cox proportional hazards models indicated that PTR was a significantly protective factor for TECDM patients in OS (HR: 0.5529; 95% CI, 0.5196 to 0.7730, P < 0.001) and CSS (HR:0.5869 ; 95% CI, 0.479 to 0.7192, P < 0.001). In conclusion, primary tumor resection is associated with improved overall survival and cancer-specific survival in thoracic esophageal cancer patients with distant metastasis.Keywords
All Related Versions
Funding Information
- Guangzhou Basic Research Project (202201011326)
- National Natural Science Foundation of China (82102955)
This publication has 29 references indexed in Scilit:
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Clinical Features of Recurrence Pattern with Lung Metastasis After Radical Esophagectomy for Thoracic Esophageal CancerWorld Journal of Surgery, 2022
- Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence?Cirugía Española (English Edition), 2021
- Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancerCancer Medicine, 2019
- The role of surgery in advanced disease for esophageal and junctional cancerBest Practice & Research Clinical Gastroenterology, 2018
- Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD databaseEuropean Journal of Cancer, 2018
- Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?Bulletin of Mathematical Biology, 2018
- Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer PatientsJournal of Thoracic Oncology, 2016
- Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancerBritish Journal of Surgery, 2014
- Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patientsBreast Cancer Research and Treatment, 2006